| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.2M | +73.8% | -26.9% |
| R&D Expense | $26.0M | -0.8% | -18.4% |
| SG&A Expense | $8.9M | +1.7% | -24.2% |
| Operating Income | -$34.4M | -20.7% | -21.8% |
| Pre-tax Income | -$32.2M | -23.6% | -30.4% |
| Income Tax | $0 | — | — |
| Net Income | -$32.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $58.8M | -24.8% | -1.4% |
| Accounts Receivable | $6.5M | +203.2% | -36.7% |
| Current Assets | $206.9M | -7.9% | -24.3% |
| Total Assets | $265.5M | -10.5% | -29.4% |
| Current Liabilities | $35.9M | -19.1% | -17.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$76.5M | — | — |
| Capital Expenditures | $596K | — | — |
| Investing Cash Flow | $72.1M | — | — |
| Financing Cash Flow | $7.7M | — | — |
| Free Cash Flow | -$77.1M | — | — |
| -30.4% |
| EPS (Basic) | -$0.44 | -18.9% | -25.7% |
| EPS (Diluted) | -$0.44 | -18.9% | -25.7% |
| $111.1M |
| -9.3% |
| -16.7% |
| Stockholders' Equity | $154.4M | -11.3% | -36.4% |